CV Lattes
Universidade Estadual Paulista (UNESP). Campus de Araraquara. Faculdade de Ciências Farmacêuticas (FCFAR) (Institutional affiliation from the last research proposal) Birthplace: Brazil
Has experience in Pharmacy, focusing on Pharmacy (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| TITULO |
| Articles published in other media outlets (0 total): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Thiazolidinediones (TZDs) are drugs used to treat type 2 diabetes mellitus (DM2), its mechanism of action occurs by activating PPAR-³ (peroxisome proliferator activated receptors)receptors in the cell nucleus which regulates the expression of genes that affect glucose and lipid metabolism, affects anti-inflammatory activity, decrease blood pressure, cholesterol and triglycerides as well a…
Thiazolidinediones (TZDs), also known as glitazones, are drugs used in the treatment of diabetes mellitus type 2 (DM2) and act primarily by reducing peripheral insulin resistance. TZDs act by activating the nuclear receptor PPAR-g (peroxisome proliferator-activated receptors) which regulates the expression of genes related to glucose and lipid metabolism, responsible for glucose uptake me…
The Laboratory of Preclinical Pharmacokinetics of New Drugs and Medicines is a research group involved in the pharmacokinetics study of new drugs in Brazil. Many new compounds are found with unfavourable pharmacokinetics characteristics despite observable pharmacologic effect. The explanation may be in the metabolites of these drugs, therefore the study of these products will improve the …
| 3 / 2 | Completed scholarships in Brazil |
| 1 / 1 | Completed scholarships abroad |
| 4 / 3 | All Scholarships |
| Associated processes | |